🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523587-20-00
Authorised Phase I

A trial to investigate the safety and pharmacokinetics of GRT6019 in healthy male participants.

2025-523587-20-00 · tracked via the Priya Life Science EU tracker
Sponsor
Gruenenthal GmbH
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
19/12/2025
Enrollment target
24
Sites
France

Condition studied

Not applicable for phase I study

Eligibility

Age group
18-64 years
Sex
Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523587-20-00 on CTIS ↗ ← All trials in the EU